Mass drug administration for trachoma: how long is not long enough?

• Autori principali: Violeta Jimenez (Autore), Huub C Gelderblom (Autore), Rebecca Mann Flueckiger (Autore), Paul M Emerson (Autore), Danny Haddad (Autore)
• Natura: Libro
• Pubblicazione: Public Library of Science (PLoS), 2015-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

BACKGROUND:Blinding trachoma is targeted for elimination by 2020 using the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements). Annual mass drug administration (MDA) with azithromycin is a cornerstone of this strategy. If baseline prevalence of clinical signs of...